Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022

世界のワクチン市場:伝染病、ガン、アレルギー、糖尿病、心血管疾患など

◆タイトル:Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022
◆商品コード:MD 2020
◆調査・発行会社:MarketsandMarkets
◆発行日:2013年8月
◆ページ数:195
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User(~5名)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate licence(社内共有可) USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界のワクチン市場:伝染病、ガン、アレルギー、糖尿病、心血管疾患など"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場の成長要因、阻害要因、バリューチェーン分析、市場の動態、制度・規制状況、技術別分析、種類別分析、市場規模及び予測、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

The vaccine market is an established segment and is widely accepted as an indispensable division of the healthcare industry. It is poised to grow rapidly by addressing the following: emerging infectious agents, various types of cancer, allergies, cardiovascular diseases, diabetes, smoke cessation, and neurodegenerative disorders. The global vaccine market is estimated at $32.05 billion in 2013 and is expected to reach $84.44 billion by 2022.

In general, the vaccine market is largely perceived negatively as a low-profit venture owing to the domination of top five companies, namely, Sanofi (France), Glaxo Smithkline (U.K.), Merck (U.S.), Pfizer (U.S.), and Novartis (Switzerland). Furthermore, a strong patent portfolio and the need for large investments towards vaccine development have limited the scope of entry for new companies.

The vaccine market is analyzed both in terms of qualitative (technological) and quantitative (revenue) perspectives. The technological analysis includes a discussion on different classes of vaccines, vaccine adjuvants, and commercially available products. The market revenue analysis includes market segmentation and the expected market position by 2022, with the projected growth rate.

The vaccine market is classified by technology class, types, end users, disease indication, and geography. The details on the emerging approaches to vaccine development such as reverse vaccinology, personalized vaccinomics, and systems vaccinomics are discussed. Furthermore, key research centers, with their critical areas of research in the vaccine space, have been provided.

An overview of regulations across various geographical regions has been covered. The complete value chain of the vaccine market is schematically represented and the significance of each stakeholder has been briefed.

Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards vaccine development. Insights on current and future technological investment trends have also been discussed.

A large number of potential therapeutic and preventive vaccine candidates addressing various diseases which are in the pipeline are listed with their current status in clinical trials.
The adoption and developmental potential of the vaccine technology market has been discussed on a geographic basis, namely, North America, Europe, Asia, and the Rest of the World, by taking select countries that are poised to have a greater market value during the forecast period.

In brief, this research report provides:

A detailed description of the global technology developments and evolving trends in the vaccine field with key prominence on research innovations, collaborative efforts, and investments for vaccines.
A close view on the therapeutic vaccines for various diseases by providing details and status of current vaccines in the pipeline.
An impact analysis of the major drivers and restraints influencing the adoption and growth of the vaccine market during the period of 2013 to 2022.
Porters five forces analysis and GAP analysis.
The global market forecast for 2013 – 2022, including demand side analysis and strategic recommendations for technology/product developers.
Competitive landscape tracking industry activities such as mergers, acquisitions, partnerships, collaborations, and strategic agreements within the vaccine market. Intellectual property strength analysis based on the number of patents filed by the top five players within the vaccine market that gives an insight into prominent activities and global leaders of the industry.

Scope of the Report

This research report categorizes the global vaccine market into technology class, types, end users, disease indication, and geography. Each segment is further broken down by geography, with exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2022.

Global Vaccine Market, by Technology Class

Live
Toxoid
Conjugate
Sub-Unit
Recombinant Vector Vaccines
DNA Vaccines
Synthetic Vaccines
Dentritic Vaccines

Global Vaccine Market, by Types

Preventive
Therapeutic

Global Vaccine Market, by End Users

Pediatric
Adult

Global Vaccine Market, by Disease Indication

Infectious Diseases
Cancer
Allergies
Others

Global Vaccine Market, by Geography

North America
Europe
Asia-Pacific
Rest of the World (RoW)

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 19)
1.1 Key Take-Aways
1.2 Report Scope
1.3 Report Segmentation
1.4 Research Methodology
1.5 Key Data Points From Secondary And Primary Sources
1.6 Logical Assumptions In This Study Based On Reliable Sources

2 Executive Summary (Page No. – 26)

3 Technology Snapshot (Page No. – 31)
3.1 Technology-Introduction
3.2 Technology-Evolution
3.3 Technology Segmentation
3.4 Technology Trends-By Class
3.4.1 Adjuvants
3.5 Key Vaccine Products In The Market
3.6 Technology Roadmap

4 Vaccine Research Portfolio (Page No. – 42)
4.1 Global Research Portfolio-Research And Development Network
4.2 Emerging Approaches To Vaccine Developments
4.3 Key Research Centres

5 Value Chain Analysis (Page No. – 47)
5.1 Overview
5.2 Cold Chain Management
5.3 Key Stakeholders
5.4 Gap Analysis
5.5 Porters Five Force Analysis

6 Market Landscape (Page No. – 57)
6.1 Global Vaccine Technologies Market, Global Forecasts (2013-2022)
6.1.1 Global Vaccine Technologies Market, By Geography, 2012-2022
6.1.2 Vaccine Technologies Market Segmentation
6.1.3 Market Dynamics
6.1.3.1 Drivers
6.1.3.2 Restraints
6.1.3.3 Opportunities, Threats And Challenges
6.2 Global Vaccine Technologies Market, By End-User, 2012-2022
6.2.1 Global Vaccine Technologies Market Share, By End-User, 2012-2022
6.2.2 Paedriatic Vaccine Market, By Geography
6.2.3 Global Paedriatic Vaccine Market Share, By Geography
6.2.4 Global Adult Vaccine Market, By Geography
6.2.5 Global Adult Vaccine Market Share, By Geography
6.3 Global Vaccine Technologies Market, By Type, 2012-2022
6.3.1 Global Vaccine Technologies Market Share, By Type, 2012-2022
6.3.2 Global Preventive Vaccine Market, By Geography, 2012-2022
6.3.3 Global Preventive Vaccine Market Share, By Geography, 2012-2022
6.3.4 Global Therapeutic Vaccine Market, By Geography, 2012-2022
6.3.5 Global Therapeutic Vaccine Market Share, By Geography, 2012-2022
6.4 Global Vaccine Technologies Market, By Class, 2012-2022
6.4.1 Global Vaccine Technologies Market Share, By Class, 2012-2022
6.4.2 Live/Attenuated Vaccine Market, By Geography
6.4.2.1 Live/ Attenuated Vaccine Market Share, By Geography
6.4.3 Toxoid Vaccine Market, By Geography
6.4.3.1 Toxoid Vaccine Market Share, By Geography
6.4.4 Conjugate Vaccine Market, By Geography
6.4.4.1 Conjugate Vaccine Market Share, By Geography
6.4.5 Sub-Unit Vaccine Market, By Geography
6.4.6 Recombinant Vector Vaccine Market, By Geography, 2012-2022
6.4.7 Dna Vaccine Market, By Geography, 2012-2022
6.4.8 Synthetic Vaccine Market, By Geography, 2012-2022
6.4.8.1 Synthetic Vaccine Market Share, By Geography, 2012-2022
6.4.9 Dentritic Vaccine Market, By Geography, 2012-2022
6.5 Vaccine Technology Market, By Disease Indication (2012 – 2022)
6.5.1 Infectious Disease Vaccine Market, By Geography
6.5.2 Cancer Vaccine Market, By Geography
6.5.3 Allergy Vaccine Market, By Geography
6.5.4 Others Vaccine Market, By Geography, 2012-2022
6.5.5 Others Potential Market, By Geography, 2016-2022

7 Technology Adoption (Page No. – 110)
7.1 Factors That Drive Adoption Of Vaccine Technologies (Demand And Supply Side Analysis)
7.2 North America-U.S. & Canada
7.3 Europe-U.K, Germany, France, Italy
7.4 Asia-China, India
7.5 RoW-Australia & Africa

8 Investment Analysis (Page No. – 122)
8.1 Investor Network
8.2 Investment Funding Analysis
8.3 Top Funding Organizations

9 Competitive Landscape (Page No. – 126)
9.1 Competitive Landscape Analysis-Overview
9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2012-2013)
9.3 Vaccine Candidates In Pipeline-Allergy
9.4 Vaccine Candidates In Pipeline-Cancer
9.5 Vaccine Candidates In Pipeline-Infectious Diseases
9.6 Vaccine Candidates In Pipeline-Others

10 Regulatory Landscape (Page No. – 135)
10.1 Regulatory Landscape-Overview
10.2 Regulations-Geographic

11 Patent Analysis (Page No. – 140)
11.1 Patent Analysis-Overview
11.2 Patent Analysis By Company

12 Analyst Recommendations (Page No. – 143)
12.1 Introduction
12.2 Technology Management Strategies

13 Company Profiles (Page No. – 146)
13.1 Novartis AG
13.2 Glaxo Smithkline PLC
13.3 Merck & CO., INC.
13.4 Sanofi
13.5 Pfizer, INC.
13.6 Antigen Express, INC.
13.7 Aduro Biotech
13.8 Genticel
13.9 Biondvax Pharmaceuticals LTD
13.10 Immune Targeting Systems (ITS)
13.11 Prokarium
13.12 Immunobiology LTD
13.13 Liquidia Technologies
13.14 Alphavax
13.15 Bavarian Nordic

14 Appendix (Page No. – 177)
Inter-Country Comparison Of Mortality For Selected Cause Of Death

List Of Tables (22 Tables)


Table 1 Vaccine Technologies Market, By Geography, 2012-2022 ($Billion)
Table 2 Global Vaccine Technologies Market, By End-User, 2012-2022 ($Billion)
Table 3 Paedriatic Vaccine Technology Market, By Geography, 2012-2022 ($Billion)
Table 4 Adult Vaccine Technology Market, By Geography, 2012-2022 ($Billion)
Table 5 Global Vaccine Technologies Market, By Type, 2012-2022 ($Billion)
Table 6 Global Preventive Vaccine Technology Market, By Geography, 2012-2022 ( $Billion)
Table 7 Therapeutic Vaccine Technology Market, By Geography, 2012-2022 ($Billion)
Table 8 Global Vaccine Technologies Market, By Technology Class, 2012-2022 ($Billion)
Table 9 Global Live Vaccine technology Market, By Geography, 2012-2022 ($Billion)
Table 10 Toxoid Vaccine Market, By Geography, 2012-2022 ($Billion)
Table 11 Conjugate Vaccine Market, By Geography, 2012-2022 ($Billion)
Table 12 Subunit Vaccine Technology Market, By Geography, 2012-2022 ($Billion)
Table 13 Recombinant Vector Vaccine Market, By Geography, 2012-2022 ($Billion)
Table 14 Dna Vaccine Market, By Geography, 2012-2022 ($Billion)
Table 15 Synthetic Vaccine Technology Market, By Geography, 2012-2022
Table 16 Dentritic Vaccine Technology Market, By Geography, 2017-2022 ($Billion)
Table 17 Global Vaccine Technology Market, By Disease Indication, 2012-2022 ($Billion)
Table 18 Infectious Disease Vaccine Market, By Geography, 2012-2022 ($Billion)
Table 19 Cancer Vaccine Technology Market, By Geography, 2012-2022 ($Billion)
Table 20 Allergy Vaccine Technology Market, By Geography, 2012-2022 ($Billion)
Table 21 Others (Cardiovascular Disease, Diabetes, Smoke Cessation) Potential Market,By Geography, 2016-2022 ($Billion)
Table 22 Revenue Of Top 5 Companies


List Of Figures (53 Figures)


Figure 1 Global Vaccine Technology Market, 2007-2012 ($Billion)
Figure 2 Global Vaccine Technologies Market,2012-2022 ($Billion)
Figure 3 Porter’s Value Chain Analysis
Figure 4 Global Vaccine Technology Market, 2007-2012 ($Billion)
Figure 5 Global Vaccine Technologies Market, 2013-2022 ($Billion)
Figure 6 Vaccine Technologies Market, By Geography, 2012-2022 ($Billion)
Figure 7 Vaccine Technologies Market Share, By Geography, 2012-2022
Figure 8 Global Vaccine Technologies Market, By End-User, 2012-2022 ($Billion)
Figure 9 Global Vaccine Technologies Market Share, By End-User, 2012-2022
Figure 10 Paedriatic Vaccine Technology Market, By Geography, 2012-2022
Figure 11 Paedriatic Vaccine Technology Market Share, By Geography, 2012-2022
Figure 12 Adult Vaccine Technology Market, By Geography, 2012-2022
Figure 13 Adult Vaccine Technology Market Share, By Geography, 2012-2022
Figure 14 Global Vaccine Technologies Market, By Type, 2012-2022
Figure 15 Global Vaccine Technologies Market Share, By Type, 2012-2022
Figure 16 Preventive Vaccine Technology Market, By Geography, 2012-2022
Figure 17 Preventive Vaccine Technology Market Share, By Geography, 2012-2022
Figure 18 Therapeutic Vaccine Technology Market, By Geography, 2012-2022
Figure19 Therapeutic Vaccine Technology Market Share, By Geography, 2012-2022
Figure 20 Global Vaccine Technologies Market, By Technology Class, 2012-2022 ($Billion)
Figure 21 Global Vaccine Technologies Market Share, By Class, 2012 - 2022
Figure 22 Live/Attenuated Vaccine Technology Market, By Geography, 2012-2022
Figure 23 Live/Attenuated Vaccine Technology Market Share, By Geography, 2012-2022
Figure 24 Toxoid Vaccine Technology Market, By Geography, 2012-2022
Figure 25 Toxoid Vaccine Technology Market Share, By Geography, 2012-2022
Figure 26 Conjugate Vaccine Technology Market, By Geography, 2012-2022
Figure 27 Conjugate Vaccine Technology Market Share, By Geography, 2012-2022
Figure 28 Subunit Vaccine Market, By Geography, 2012-2022 ($Billion)
Figure 29 Sub-Unit Vaccine Market, By Geography, 2012-2022
Figure 30 Recombinant Vector Vaccine Market, By Geography, 2012-2022
Figure 31 Recombinant Vector Vaccine Market Share, By Geography, 2012-2022
Figure 32 Dna Vaccine Technology Market, By Geography, 2012-2022 ($Billion)
Figure 33 Dna Vaccine Market, By Geography, 2012-2022
Figure 34 Synthetic Vaccine Technology Market, By Geography, 2012-2022
Figure 35 Synthetic Vaccine Technology Market Share, By Geography, 2012-2022
Figure 36 Dentritic Vaccines, By Geography, 2012-2022
Figure 37 Dentritic Vaccine Technology Market Share, By Geography, 2012-2022
Figure 38 Global Vaccine Technology Market, By Disease Indication, 2012-2022
Figure 39 Global Vaccine Technology Market Share, By Disease Indication, 2012-2022
Figure 40 Infectious Disease Vaccine Technology Market, By Geography, 2012-2022
Figure 41 Infectious Disease Vaccine Technology Market Share, By Geography, 2012-2022
Figure 42 Cancer Vaccine Technology Market, By Geography, 2012-2022 ($Billion)
Figure 43 Cancer Vaccine Technology Market, By Geography, 2012-2022
Figure 44 Allergy Vaccine Technology Market, By Geography, 2012-2022
Figure 45 Allergy Vaccine Technology Market Share, By Geography, 2012-2022
Figure 46 Others (Cardiovascular Disease, Diabetes, Smoke Cessation) Potential Market,By Geography, 2016-2022 ($Billion)
Figure 47 Others (Cardiovascular Disease, Diabetes, Smoke Cessation) Potential Market,By Geography, 2016-2022
Figure 48 Global Vaccine Technologies Market,By Geography, 2012-2022
Figure 49 Vaccine- Investor Network
Figure 50 Global Vaccine Market Share,By Key Player, 2013
Figure 51 Regulatory Approval Process
Figure 52 Total Patents Filed Between 2008-2013
Figure 53 Patent Analysis By Companies (2008-2012)

★調査レポート[世界のワクチン市場:伝染病、ガン、アレルギー、糖尿病、心血管疾患など] ( Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022 / MD 2020) 販売に関する免責事項
[世界のワクチン市場:伝染病、ガン、アレルギー、糖尿病、心血管疾患など] ( Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022 / MD 2020) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆